Skip to content
10-Q

Quarterly Report

HealthLynked Corp. HLYK

0001213900-24-068949

← back to feed
Filed
Aug 14, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 14, 2024 281.95M sh
Cash And Equivalents Q2 2024 · Jun 30, 2024 $172.7K
Cash And Equivalents Q2 2024 · Dec 31, 2023 $247.22K
Current Liabilities Q2 2024 · Jun 30, 2024 $3.4M
Current Liabilities Q2 2024 · Dec 31, 2023 $2.41M
Total Liabilities Q2 2024 · Jun 30, 2024 $4.28M
Total Liabilities Q2 2024 · Dec 31, 2023 $3.48M
Current Assets Q2 2024 · Jun 30, 2024 $2.01M
Current Assets Q2 2024 · Dec 31, 2023 $656.16K
Total Assets Q2 2024 · Jun 30, 2024 $3.86M
Total Assets Q2 2024 · Dec 31, 2023 $4.28M
Total Assets restated Q2 2024 · Jun 30, 2023 $5.21M
Shares Diluted Q2 2024 · Jun 30, 2023 259.82M sh
Shares Diluted Q2 2024 · Jun 30, 2023 258.48M sh
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$1.7M
Stockholders Equity Q2 2024 · Jun 30, 2023 $1.57M
Stockholders Equity Q2 2024 · Mar 31, 2023 $2.17M
Stockholders Equity Q2 2024 · Dec 31, 2022 $314.45K
Eps Diluted Q2 2024 · Jun 30, 2023 $0.00
Eps Diluted Q2 2024 · Jun 30, 2023 $0.00
Eps Basic Q2 2024 · Jun 30, 2023 $0.00
Eps Basic Q2 2024 · Jun 30, 2023 $0.00
Sga Expense Q2 2024 · Jun 30, 2023 $833.69K
Sga Expense Q2 2024 · Jun 30, 2023 $1.94M
Net Income Q2 2024 · Jun 30, 2023 −$1M
Net Income Q2 2024 · Jun 30, 2023 $448.48K
Net Income Q2 2024 · Mar 31, 2023 $1.45M
Operating Income Q2 2024 · Jun 30, 2023 −$798.09K
Operating Income Q2 2024 · Jun 30, 2023 −$1.85M